ISERA Q2: STANDALONE NET LOSS NARROWS TO ₹0.13 CR (QOQ) FROM ₹0.34 CR; REVENUE NIL, YOY NA. WEAK (ON 1ST LOOK)

• Revenue from operations nil; total income ₹7.88 L from other income (QOQ). • Total expenses ₹20.99 L v ₹33.62 L (QOQ). • Net loss ₹0.13 Cr v ₹0.34 Cr (QOQ); EPS -₹0.62 v -₹1.60 (QOQ). • Cash and cash equivalents ₹3.55 L at 30 Sep 2026 v ₹75.59 L at 30 Jun 2026. Impact: Loss narrowed QoQ but revenue remains nil and cash fell sharply.

iSERA Lifesciences Ltd

Open attachment

← Back to feed